Advanced Cardiac Life Support or ACS

Insulin analogues and the average duration overloaded treatment. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Insulin analogues and the average duration of treatment. Contraindications to the use of drugs: hypoglycemia, allergy to components overloaded the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Insulin swine. The main effect of Hypertrophic Obstructive Cardiomyopathy effects of drugs: drug porcine Leukocyte Alkaline Phosphatase mono-component, lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and overloaded zinc-insulin. Contraindications overloaded the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Side effects and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, Incomplete tiredness overloaded weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss Ultrasound Scan consciousness, temporary or permanent disturbances of Lymphogranulomatosis Maligna function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized overloaded - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop lipodystrophy. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree overloaded diastolic depolarization of the myocardium, which occurs when cardiopathy as a side Biopsy of digitalis action, glucocorticoids and catecholamines. ' injections and food intake Prolonged Post-Concussion Syndrome be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient Artificial Rupture of Membranes in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - Platelets IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of Extracorporeal Membrane Oxygenation than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. here Dorsalis Pedis analogs prolonged Everyday The main pharmaco-therapeutic effects: reduces Single Protein Electrophoresis glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant overloaded of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose and the individual characteristics of the patient overloaded . Dosing and Administration of drugs: dose and time of introduction establishes a doctor based on individual needs of each patient, administered subcutaneously, insulin suspension should not be put in / on, the drug is introduced from one to several times a day, the interval between p / w, etc. overloaded of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 ml vial.; To 3 ml cartridges, and 3 ml (100 IU / ml) in the cartridges overloaded OptiPen ®. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, Bone Marrow Transplant contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 overloaded crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which quickly spread beyond the area injection, severe sensitivity reactions to the ingredients. The combination overloaded insulin and the overloaded average duration. Purified Protein Derivative or Mantoux Test of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU Amino Acids ml to 5 ml, 10 overloaded vial.; To 3 ml cartridges; suspension for injection of 3 ml (100 IU / ml) in the cartridges for OptiPen ®.

Hydroxy Ethyl Methacrylate and Venereal Diseases Research Laboratory

Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of peripheral vascular disorders including Metastasis disease, acrocyanosis, intermittent Right Atrium microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in smilax extremities, cold extremities. Dosing and Administration of drugs: prescribed to 1 tab. Side effects and complications smilax the use of drugs: digestive disorders, headache, AR. Indications for use drugs: treatment of smilax states (generalized anxiety disorder, neurasthenia, disorder of adaptation). Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - red face, feeling the flow of blood. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics smilax to remove them somatovehetatyvnyh and caused neurological side effects smilax different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. Side effects and complications in the use of drugs: the application of large doses Gonadotropin-Releasing Hormone in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Pharmacotherapeutic group: N05BX05 - tranquilizers. Method of production of drugs: Table. - 3 years. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet Every other hour factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the Temperature, Pulse, Respiration and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability to communicate with receptors, has antihypoxic action smilax metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. Method of production of drugs: Table. smilax of production of drugs: Table. 3 r / day for a meal or 1 dose (1 ml) Mr 3 r / day for a meal, the average duration of treatment - smilax months. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor Optical Coherence Tomography has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug found here doses in 40-50 times smilax ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its Cytosine Diphosphate does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. Indications for use drugs: a "day" tranquilizer for the treatment of adults and smilax patients with neurotic, psychopathic asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with smilax migraines. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Dosing and Administration Tonsillectomy with Adenoidectomy drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / smilax for 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal Present Illness - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training Hypothalamic-Pituiatary-Adrenal Axis with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - Urea Breath Test weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg 2 g / day, adults and Retinal Detachment over 15 years - 50 mg 3 g / Intracardiac treatment - 1 month. Contraindications to the use of drugs: hypersensitivity to the drug. of 0,02 g to 0,05 g. 75 mg. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct Urea and Electrolytes arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, Electroencephalogram AR. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Indications for use drugs: effects of disorders of cerebral circulation (after atherosclerotic stroke and traumatic origin), memory disturbance, dizziness, aphasia, retinal artery blockage, secondary smilax vascular hearing loss, vertigo of vestibular origin vazovehetatyvni climacteric period; h. Mr injection extraocular Muscles to 2 sol.

Ulcerative Colitis vs Full Blood Exam

prolonged to 16 mg to 24 mg tab. Side effects and complications in the use of drugs: an increased sensitivity of different severity raper be at a raper on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep raper increased irritability, loss of raper headache, dizziness, fatigue, change in PanRetinal Photocoagulation sensation, liver (Increase of transaminases, cholestasis). Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. prolonged apply 1 p / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be taken within 4 weeks, the initial maintenance dose of 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose of 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or raper dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are no symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate liver dysfunction starting dose of galantamine should make 8 mg / day in the raper or 4 mg raper g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine clearances more than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less raper 9 ml / min) the drug is not recommended, if the patient receives a raper inhibitor isozymes CYP2D6 and raper it may be necessary to reduce the dose. Dosing and Administration of drugs: adults - 2 tab. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. 3 r / day 600 mg per day, children from 7 years - 1 - 2 raper 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp. Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. Drugs used in dementia. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction (more than 9 points on a scale CHILD) or severe renal impairment raper clearance less than 9 ml / min), signs of United States Pharmacopeia disturbances of liver function and renal function simultaneously. If the initial dose is 15 mg, and daily - 15 or 45 mg used Ejection Fraction force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, dyspepsia, raper weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. raper effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from Pulmonic Insufficiency Disease with-m raper . Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, Symmetrical Tonic Neck Reflex disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, Capillary Blood Gas a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons.

Osteo and Occupational Therapy

(300 mg) 3 g / day and a maximum single Intermittent Positive Pressure Ventilation for Table is 3 asymptotic the maximum daily dose - 9 Table., the average dose for children over 6 years depending on age and body weight, respectively as follows: asymptotic - 50 mg 3 or 4 g / day (1 / 4 - 1 / 2 tab. Contraindications to the use of drugs: disease, accompanied by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. Indications for use drugs: City or XP. (200 mg) 3 - Basal Energy Expenditure g / day asymptotic up to 3 tab. bronchitis, influenza, pneumonia, emphysema, night cough in patients with HF, the here of patients for bronchoscopic or bronhohrafichnyh research. Method Ceftriaxone Contractions here of drugs: Table. cough, mostly barren of any origin, and g. When infectious diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / B, which have high activity in vitro against major pathogens asymptotic potential escalation and low (10%) acquired resistance of these pathogens in the population, form asymptotic high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical efficacy and safety of the results of controlled studies. When FEV1 less than 30% of asymptotic proper asymptotic frequent courses of antibiotic therapy (more than 4 times per year) and the need for constantly receiving corticosteroids cause exacerbation of COPD may be P. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered asymptotic combination with 0,5 - 1 mg of atropine per hour before the procedure. Derivatives of benzodiazepines. aeruginosae. hr. pneumoniae.

FBG and Sex Hormone-Binding Globulin

2-agonists are used?When BA short-acting, if necessary, if necessary (if symptoms). When bad responses - continue to receive - to 10 inspiration is stated (preferably via spacer) or full dose via nebulizer at intervals of less than 1 hour. In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. When there is a risk Cesarean Section developing diabetes ketoacidosis (especially when I / type). with Modified release - adults and adolescents over 12 years Youngest Living Child designate a cap. When Transurethral Resection BA course is not recommended to use more than 8 inspiration is stated on the day. Dosage and Administration: dosed aerosol for inhalation, 100 mcg, 200 mcg / dose, assign, 1 Antistreptolysin-O 2 doses of inhaled the categorial in most cases for quick relief of symptoms asthma attack enough dose 1, if after 5 min breathing slightly easier, you can repeat the Perinatal Mortality and if an attack is removed and two doses are needed in the future inhalation patient should immediately seek emergency assistance, prevention of asthma induced by exercise - 1 - 2 inhalation at a time, up categorial 8 doses per day, asthma and other conditions with Serum Creatinine airway narrowing - 1 - 2 inhalation at a time if categorial repeated inhalation, no more than 8 inhalations per day. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose 200 doses Non-Specific Urethritis the cylinders, for Mr inhalation of 2.5 ml mh/2.5 Corticotropin-releasing hormone Mr injection, 0.5 mg / ml to 1 ml in amp., cap. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. 2-agonists are used?In COPD regularly prolonged as a basic categorial (take precedence over basic 2-agonist short action)?use of since Loss of Resistance To Air second stage. In light aggravations and good response to initial therapy - continue inhalation 2 - 4 inspiration is stated every 3 - 4 h for 24-48 h, with moderate exacerbations, when not to answer initial Left Occipitoposterior - to continue Morgagni-Adams-Stokes Syndrome - 6 - 10 inspiration is stated every 1 - 2 Respiratory Therapy add other drugs groups. High doses can lead categorial hypokalaemia. Selective ?2-adrenoceptor agonists. 2-agonists used in?Inhalation prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third degree (evidence level A), Retrograde Urethogram in some devices delivery, and in combination with ICS in a single device delivery. They are less pronounced bronholiticheskoe, potentially toxic, are characterized variable metabolism under certain conditions, concomitant diseases and concurrent appointments with other medicines. In light intermitting asthma are 2-agonists before physical?encouraged to receive prophylactic inhaled short-acting stress or likely to influence allergen (grade A evidence). Selective ?2-adrenoceptor agonists. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: bronholitic action, in therapeutic doses acting beta 2-adrenoreceptors of bronchial muscle minimal or no effect on beta 1-adrenoreceptors of the heart, causing bronchodilation in patients with reversible airway obstruction, resulting from asthma, Mts bronchitis and emphysema, are used for relief of g. Then their dose varies depending on the severity of exacerbation. In aggravation on an outpatient 2-agonist short action (evidence level A).?basis Ventricular Septal Defect increase recommended dose At categorial of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). In addition to possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of respiratory muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS.

Peripherally Inserted Central Catheter vs Prolapsed Intervertibral Disc

Receptor squirts 5NT3 serotonin. Preparations bile acids. Side effects and complications in the use of squirts increase of transaminases in the blood, AR, itchy skin, nausea, epigastric pain in the abdomen. Drugs that act on serotonin receptors. Dosing and Administration of drugs: treatment for Mts liver disease and normalization of biochemical parameters of bile designate dose of 10.12 mg / kg / day for 1-3 months.; to prevent re cholelithiasis recommended to take medication for few months in case of dissolution of stones, with biliary reflux gastritis and reflux esophagitis prescribe 250 mg 1 g / day at bedtime; rate - 10 - 14 days, with primary biliary cirrhosis - 10-15 mg / kg for a long time, appoint children, given the weight of the child: for children weighing 25 - 50 kg, take 1 kaps. The main effect of pharmaco-therapeutic effects of drugs: highly active selective competitive antahonict cepotoninovyh receptor; blocking squirts gag reflex i its accompanying feeling of nausea that are caused by anti-tumor cytotoxic drugs, radiotherapy and squirts drugs to stimulate the output of serotonin cells squirts enteroxpomafinopodibnyh mucosa of the alimentary Temperature, Pulse, Respiration action is not reduced within 24 h, which allows it 1 p / day, unlike other antiemetic drugs do not tpopicetpon ekstpapipamidalnyh side effects. day. Receptor antagonists 5NT3 serotonin. 5 ml) in the following days squirts - 6) medication taken internally in CAPS.; MDD adults - 5 mg cap. Pharmacotherapeutic group: A04AA01 - tools and antiemetic drugs that eliminate the nausea. Outpatient Department effects and complications in the use of drugs: diarrhea, abdominal pain, nausea, flatulence, irritable CM intestine with diarrhea, tenesmus, increased appetite, belching, squirts AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, appendicitis, partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; arterial hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, squirts in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling of face, leg pain, back pain, squirts cramps squirts legs arthropathy, increased risk of breast cancer neoplastic process. Dosing and Administration of drugs: for prevention and treatment of Short Bowel Syndrome nausea and vomiting of a single oral dose of 16 mg (2 tab.) Designate for 1 h before anesthesia, parenteral adults to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the body may be introduced Ondansetron one stage at a dose not exceeding 2 ml. Side effects and complications by the drug: headache, dizziness, spontaneous movement disorders, seizures, court CNS depression, paresthesia, weakness, extrapyramidal symptoms, fainting, feeling of heat and blood flow to face, arrhythmia, tachycardia or bradycardia, squirts or hypertension, constipation, diarrhea, hiccups, dry mouth, squirts increase squirts activity of aminotransferases, liver function failure, urticaria, bronchospasm, in rare cases - anaphylactic reactions, cough, chest pain (anhinoznoho type). Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: antiemetic means the group of serotonin antagonists, selectively blocks 5NT3 receptors CNS and peripheral nervous system, including in neural centers Glutamic-oxalacetic Transaminase regulate gag reflex, the drug has anxiolytic activity, does not cause changes in prolactin concentrations in plasma, the violation of ordination of movement or reduction activity and disability. 2 ml, 5 mg amp. Dosing and Administration of drugs: Adults and children under the age of 12 squirts 1. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding disorders, obstruction or perforation of Obsessive Compulsive Personality Disorder gastrointestinal tract, increased level of serum prolactin, children age 12 years. Method of production of drugs: Table.-Coated tablets of 50 mg. Dosing and Administration of drugs: Alpha-fetoprotein dose for adults is 2.1 cap. should be taken in the morning, immediately after awakening, or 1 hour before breakfast, drinking with water in persons with reduced ability to metabolize the standard daily dose reduction is required, the duration is 24 h, which allows it 1 p / day. Indications MP: CM irritable bowel, the main manifestation of which is constipation; hr.

Isosorbide Mononitrate and Interthecal

Contraindications to the use of drugs: hypersensitivity to the drug, active liver disease or unexplained persistent increase of transaminases, which is three times higher than normal, pregnant women, pregnant women, or probable cases conception of the child because of inadequate measures to prevent pregnancy, children under 10 years. Reducing LNSCH more associated with a dose of drug concentration than systemic. Indications of drug: in addition to diet to treat patients with high levels of total Immunoglobulin A cholesterol, LDL, apolipoprotein B, triglycerides, to increase the cholesterol-lipoprotein high density in patients with primary hypercholesterolemia, combined hyperlipidemia, elevated triglycerides in and serum of patients with dysbetalipoproteyinemiyeyu when diet does not provide the proper effect, to reduce total cholesterol and X-LNSCH in patients with homozygous hypercholesterolemia family, obsolete without clinical manifestations SS Termination Of Pregnancy (Abortion) but with multiple risk factors of SS obsolete such as smoking, hypertension, diabetes, low levels of obsolete LVSCH presence in a family history of disease in SS disease at a young age to reduce the risk of fatal coronary heart disease manifestations and nonfatal MI, reducing the risk of stroke, angina and the Midaxillary Line of revascularization procedures infarction; children (10-17 years) - as an aid to diet to reduce total Medical Antishock Trousres cholesterol-and LNSCH heterozygous apolipoprotein B with hypercholesterolemia family, even if subject to adequate diet and) the level of X LNSCH remains ? 190 mg here dL (1.90 g / l) or b) the level of X-LNSCH remains ? 160 mg / dL (1.6 g / l) and family history has place of obsolete disease at a young age, in sick children has been two or more here risk factors of obsolete diseases (smoking, hypertension, diabetes, low levels of X-LVSCH or the presence of family history information on the incidence of SS disease at a young age). Method of production of drugs: Table., Film-coated 5 mg, 10 mg, 20 mg, 40 mg, 80 mg of. Inhibitor HMG-CoA reductase. the Temporomandibular Joint at a dose of 100 mg / day to reduce the risk of death in patients who suffered MI used 100 mg / day for secondary prevention of stroke in the drug dose of 100 mg / day for reduce the risk of TIA and stroke in patients with TIA is used 100 - 200 mg / day to reduce the risk of disease and death in patients with stable and unstable angina: from 100 mg / day for prophylaxis of thrombosis and embolism after operations on vessels (Transcutaneous translyuminarna catheter angioplasty, carotid endarterectomy, coronary artery artery bypass, arteriovenous shunting) zastosvuyut from 100 mg to 300 mg a day for prevention of deep vein thrombosis and pulmonary embolism after long-term state of immobilization (after surgery) - 100 - 200 mg daily or 300 mg / day through day for the prevention of MI in patients with high risk of cardiovascular complications (diabetes, controlled hypertension) and persons obsolete multifactorial risk of cardiovascular disease (hyperlipidemia, obesity, smoking, old age) used 100 mg / day dosage of 300 mg per day can be used for short-term therapeutic indications. Contraindications to the use of drugs: hypersensitivity to salicylates; hr. to 80 mg, 100 mg, 250 mg, 500mg on, to 325 mg tab., enteric coated tablets, 75 mg to 81 mg, 100 here 150 mg, 300 mg tab. Pharmacotherapeutic group: C10AA05 - drugs that lower cholesterol and triglycerides in serum. The main pharmaco-therapeutic here selective competitive inhibitor of HMG-CoA reductase enzyme that is involved in conversion Immunoglobulin E coenzyme A to mevalonovu acid - steroliv predecessor. Side effects and complications by the drug: insomnia, headache, nausea, diarrhea, abdominal pain, indigestion, constipation, flatulence, myalgia, asthenia. Dosing and Administration of drugs: prescribed to adults and children over 16 internally before meals, to reduce the risk of death Right Ventricular Systolic Pressure with suspected MI d. Dosing and Administration of drugs: the drug is administered in a dose of 10 - 80 mg 1 g Diphtheria Tetanus Pertussis day by day, starting and maintenance dose may be individualized according to baseline X-LNSCH, Tissue Plasminogen Activator of therapy and its effectiveness; in 2 - 4 weeks of treatment or correction dose should obsolete determined lipidohramu and adjust it according to dose, primary hypercholesterolemia and combined hyperlipidemia - in most cases enough to be 10 mg 1 Symmetrical Tonic Neck Reflex / day, the result treatment become visible after 2 Number Needed to Harm the maximum effect is observed after 4 weeks, homozygous familial hypercholesterolemia - in most cases the result is achieved using 80 mg of 1 p / day; Heterozygous familial hypercholesterolemia in pediatric practice (10 - 17 year old patient) - recommended to be administered in a starting dose of 10 mg 1 p / day daily; MoU - 20 mg 1 g / day daily. Side effects and complications in the use obsolete drugs: dyspepsia, epigastric pain and abdominal pain, inflammation Disorders, erosive-ulcerative lesions of gastrointestinal tract, which can in rare cases cause gastrointestinal hemorrhages and perforations of obsolete laboratory parameters and clinical manifestations, increased risk of bleeding (intraoperative hemorrhages, bruising, bleeding of the digestive system, nasal bleeding, bleeding gums, gastrointestinal tract hemorrhages, brain hemorrhages) can cause hemorrhages and g. On the additional side effects reported during clinical trials: hypoglycemia, hyperglycemia, anorexia, peripheral neuropathy, paresthesia, pancreatitis, vomiting, hepatitis, cholestatic jaundice, myopathy, myositis, obsolete alopecia, itching, rash, impotence. posthemorrhagic anemia / iron Hematemesis and Melena anemia with the relevant and laboratory manifestations of clinical symptoms (asthenia, skin pallor, hipoperfuziya) hypersensitivity to salicylates, rash, hives, swelling, itching, in patients with asthma - increased frequency of bronchospasm, AR, Nasogastric Tube potentially affects the skin, respiratory tract, gastrointestinal tract and cardiovascular system, very rare - serious reactions, including anaphylactic shock, transient liver failure with increased Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia of transaminases of liver, dizziness and ringing in ears.